BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 8 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 9 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 9 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 10 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 8 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 9 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 9 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 10 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Market News

Constellation (STZ) beats Q4 revenue and earnings estimates

Constellation Brands (NYSE: STZ) reported better-than-expected revenue and earnings for the fourth quarter of 2020, allowing shares to gain over 4% in premarket hours on Friday. Net sales grew 6% year-over-year to $1.90 billion, beating estimates of $1.84 billion. Reported net income fell to $398.4 million, or $2.04 per share, from $1.23 billion, or $6.37 […]

$STZ April 3, 2020 2 min read

Constellation Brands (NYSE: STZ) reported better-than-expected revenue and earnings for the fourth quarter of 2020, allowing shares to gain over 4% in premarket hours on Friday.

Net sales grew 6% year-over-year to $1.90 billion, beating
estimates of $1.84 billion.

Reported net income fell to $398.4 million, or $2.04 per share, from $1.23 billion, or $6.37 per share, last year. Last year’s results included a gain of $1.18 billion from unconsolidated investments. On an adjusted basis, EPS rose 12% to $2.06, topping forecasts of $1.65.  

Constellation Brands beats Q4 2020 revenue and earnings estimates

Net sales in the Beer division rose 8.9% to $1.18 billion in
the fourth quarter. The business saw import beer depletion growth of 11.4% and
overall depletion growth of 10.8% driven by the Modelo and Corona Brand
Families.

In the Wine and Spirits segment, net sales gained 1.2% to
$715.4 million. Depletion growth came to over 4% for the Power Brand portfolio,
helped by double-digit growth in Kim Crawford, Meiomi and The Prisoner Brand
Family.

ADVERTISEMENT

CFO Garth Hankinson said, “We have significant capacity under
our $2 billion revolving credit facility and we plan to carefully manage our
debt position over the next 24 months. In addition, we are expecting approx. $850
million in cash upon the close of the Gallo transaction and we remain focused
on prudently navigating the challenging operating environment presented by
COVID-19.”

Constellation is not providing FY2021 EPS guidance at this
time due to potential impacts from the coronavirus outbreak. However, its
pre-COVID-19 expectations for the period reflect a net sales growth of 7-8% in
Beer including the impact of the Ballast Point divestiture. Net sales and
operating income in the Wine and Spirits division are expected to decline approx.
30-35% from the previous year.

Constellation declared a quarterly cash dividend of $0.75 per share of Class A common stock and $0.68 per share of Class B common stock, payable on May 19, 2020, to stockholders of record as of May 5, 2020.

Constellation’s investment in Canopy Growth (NYSE: CGC) yielded a loss of $31.7 million in the fourth quarter. Canopy is estimated to record a pretax loss of approx. CAD700 million to CAD800 million for its fourth quarter of 2020 and Constellation’s share of this loss will be CAD245 million to CAD280 million which it will record in Q1 2021.

ADVERTISEMENT